NDC Product
Human Prescription DrugPancreaze NDC 62541-401
- Generic Name
- Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease
- Dosage Form
- Capsule, Delayed Release
- Route
- Oral
- Marketing
- BLA
Active Listing
PANCREAZE 2,600 UNT / 15,200 UNT / 8,800 UNT Delayed Release Oral Capsule
RxNorm 2478455 NDC Crossover
NDC Directory Crossover & Product Mapping
The following National Drug Codes (NDCs) are directly associated with the clinical concept for PANCREAZE 2,600 UNT / 15,200 UNT / 8,800 UNT Delayed Release Oral Capsule (RxCUI 2478455). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.
